Search Within

Brian Kushner

  1. "GSK Faculty"
Formats
  1. Journal Article (144)
  2. Meeting Abstract (76)
  3. Conference Paper (9)
  4. Book Section (4)
Groups
  1. GSK Faculty (233)
  2. Neuroblastoma Service (233)
  3. Pediatrics, Department of (233)
  4. Tow Center for Developmental Oncology (TCDO) (233)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (230)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (227)

More Groups

People
  1. Nai-Kong Cheung (227)
  2. Shakeel Modak (137)
  3. Kim Kramer (126)
  4. Michael La Quaglia (68)
  5. Ellen Basu (61)
  6. Stephen Roberts (58)

More People

Years
  1. 2025 (1)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (6)
  5. 2021 (5)
  6. 2020 (5)

More Years

Publications
  1. Pediatric Blood and Cancer (49)
  2. Journal of Clinical Oncology (47)
  3. International Journal of Radiation Oncology, Biology, Physics (17)
  4. Cancer (13)
  5. Medical and Pediatric Oncology (9)
  6. Neuro-Oncology (8)

More Publications

Publishers
  1. Wiley Periodicals, Inc (49)
  2. American Society of Clinical Oncology (47)
  3. Elsevier Inc. (22)
  4. American Association for Cancer Research (13)
  5. Wiley Blackwell (13)
  6. Wiley Liss (9)

More Publishers

Results (233)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clonal evolution during metastatic spread in high-risk neuroblastoma
    Journal Article

    Gundem, G.; Levine, M. F.; Roberts, S. S.; Cheung, I. Y.; Medina-Martínez, J. S.; Feng, Y.; Arango-Ossa, J. E.; Chadoutaud, L.; Rita, M.; Asimomitis, G.; more...
    Nature Genetics (2023)

    Fulltext@MSK | Save
  • Effect of oral β-glucan on antibody response to ganglioside vaccine in patients with high-risk neuroblastoma: A phase 2 randomized clinical trial
    Journal Article

    Cheung, I. Y.; Mauguen, A.; Modak, S.; Ragupathi, G.; Basu, E. M.; Roberts, S. S.; Kushner, B. H.; Cheung, N. K.
    JAMA Oncology (2023)

    Fulltext@MSK | Save
  • Skeletal muscle metastases in neuroblastoma share common progenitors with primary tumor and biologically resemble stage MS disease
    Journal Article

    Fong, C.; Kushner, B. H.; Di Giannatale, A.; Gundem, G.; Li, S.; Roberts, S. S.; Basu, E. M.; Price, A.; Cheung, N. K. V.; Modak, S.
    Frontiers in Oncology (2023)

    Fulltext@MSK | Save
  • Clinical outcomes of pediatric patients receiving multimodality treatment of second central nervous system relapse of neuroblastoma
    Journal Article

    Tringale, K. R.; Wolden, S. L.; Casey, D. L.; Kushner, B. H.; Luo, L.; Pandit-Taskar, N.; Souweidane, M.; Cheung, N. K. V.; Modak, S.; Basu, E. M.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  • Immunotherapy with anti-G(D2) monoclonal antibody in infants with high-risk neuroblastoma
    Journal Article

    Kushner, B. H.; Modak, S.; Kramer, K.; Basu, E. M.; Iglesias-Cardenas, F.; Roberts, S. S.; Cheung, N. K. V.
    International Journal of Cancer (2023)

    Fulltext@MSK | Save
  • Oral beta-glucan enhanced anti-ganglioside antibody titer after vaccination against high- risk neuroblastoma: Results of a randomized trial
    Meeting Abstract

    Cheung, I. Y.; Mauguen, A.; Feng, Y.; Ragupathi, G.; Basu, E.; Roberts, S. S.; Modak, S.; Kushner, B. H.; Cheung, N. K. V.
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Plasma cell-free DNA analysis uncovered tumor heterogeneity and clonal evolution during treatment for relapsed neuroblastoma
    Meeting Abstract

    Cardenas, F. I.; Kothari, P.; Tsui, D.; Basu, E.; Roberts, S.; Cheung, N. K.; Kushner, B.; Modak, S.
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Meeting Abstract

    Modak, S.; Pandit Taskar, N.; Kushner, B.; Zanzonico, P.; Humm, J.; Donzelli, M.; Lewis, J.; Lyashchenko, S.; Chu, B.; Larson, S.; more...
    Pediatric Blood and Cancer (2022)

    Fulltext@MSK | Save
  • Naxitamab-based chemoimmunotherapy for resistant high-risk neuroblastoma: Results of "HITS" phase II study
    Meeting Abstract

    Modak, S.; Kushner, B. H.; Mauguen, A.; Castañeda, A.; Varo, A.; Gorostegui, M.; Muñoz, J. P.; Santa-Maria, V.; Basu, E. M.; Cardenas, F. I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase 1 study of intraventricular (131)I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies
    Journal Article

    Kramer, K.; Pandit-Taskar, N.; Kushner, B. H.; Zanzonico, P.; Humm, J. L.; Tomlinson, U.; Donzelli, M.; Wolden, S. L.; Haque, S.; Dunkel, I.; more...
    Journal of Hematology & Oncology (2022)

    Fulltext@MSK | Save